Social factors in liver, bile duct, and gallbladder cancer

This trial uses a simple blood test to track how well bile duct cancer responds to treatment and to predict outcomes. It may help doctors make better decisions about surgery and other therapies.

This study looks at how social factors—like health insurance coverage and community support—affect outcomes for people with hepatocellular carcinoma (HCC), a type of liver cancer. It aims to improve care and access to treatment for patients who are uninsured or underinsured.

This study follows people with bile duct cancer or certain liver cancers to better understand their disease. You might be included if you meet the diagnosis and basic participation requirements.

This study builds a research database and a “multiomics” biobank (stored samples for lab testing) from people with benign and malignant bile duct or gallbladder conditions. It may help researchers understand these diseases better and improve future testing and treatments.

This study looks at how chemicals in our environment and life stress might be linked to liver cancer. It is for people with fatty liver disease caused by metabolism or alcohol, who are having a liver biopsy.

This study tracks how bile duct and liver cancers change during treatment, to help doctors find the best therapies for patients. It is for people who are newly diagnosed or starting a new treatment.